140 results
Page 2 of 7
8-K/A
EX-10.1
crlo nyfx48w7xc3y
17 Aug 22
Departure of Directors or Certain Officers
5:20pm
8-K
EX-1.1
u0ikwru
11 Mar 22
Travere Announces Proposed Convertible Senior Notes Offering
4:06pm
424B5
14acc9mft03s0jr1plk
9 Mar 22
Prospectus supplement for primary offering
4:20pm
424B5
g6sdfhe89s0w78ps7u5
8 Mar 22
Prospectus supplement for primary offering
7:41am
8-K
EX-99.1
uzqfp8yc pmxo3d
1 Mar 21
Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
4:14pm